Cargando…

Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy

A new variant of the porcine epidemic diarrhea virus (PEDV) is an emerging swine disease, killing considerable numbers of neonatal piglets in North America and Asia in recent years. To generate immunogens mimicking the complex spike (S) protein folding with proper posttranslational modification to m...

Descripción completa

Detalles Bibliográficos
Autores principales: Chang, Chia-Yu, Hsu, Wei-Ting, Chao, Yu-Chan, Chang, Hui-Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071207/
https://www.ncbi.nlm.nih.gov/pubmed/29954081
http://dx.doi.org/10.3390/v10070346
_version_ 1783343831094132736
author Chang, Chia-Yu
Hsu, Wei-Ting
Chao, Yu-Chan
Chang, Hui-Wen
author_facet Chang, Chia-Yu
Hsu, Wei-Ting
Chao, Yu-Chan
Chang, Hui-Wen
author_sort Chang, Chia-Yu
collection PubMed
description A new variant of the porcine epidemic diarrhea virus (PEDV) is an emerging swine disease, killing considerable numbers of neonatal piglets in North America and Asia in recent years. To generate immunogens mimicking the complex spike (S) protein folding with proper posttranslational modification to mount a robust immune response against the highly virulent PEDV, two baculoviruses displaying the full-length S protein (S-Bac) and the S1 protein (S1-Bac) of the virulent Taiwan genotype 2b (G2b) PEDV Pintung 52 (PEDV-PT) strain were constructed. Intramuscular immunizations of mice and piglets with the S-Bac and S1-Bac demonstrated significantly higher levels of systemic anti-PEDV S-specific IgG, as compared with control group. Our results also showed that piglets in the S-Bac group elicited superior PEDV-specific neutralizing antibodies than those of the S1-Bac and control groups. The highly virulent PEDV-PT strain challenge experiment showed that piglets immunized with S-Bac and S1-Bac showed milder clinical symptoms with significantly less fecal viral shedding as compared with non-immunized control piglets. More importantly, piglets immunized with the S-Bac exhibited no to mild clinical signs, with a delayed, minimal viral shedding. Our results demonstrated that the S-Bac could serve as a safe, easy to manipulate, and effective vaccine candidate against the PEDV infection.
format Online
Article
Text
id pubmed-6071207
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-60712072018-08-09 Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy Chang, Chia-Yu Hsu, Wei-Ting Chao, Yu-Chan Chang, Hui-Wen Viruses Article A new variant of the porcine epidemic diarrhea virus (PEDV) is an emerging swine disease, killing considerable numbers of neonatal piglets in North America and Asia in recent years. To generate immunogens mimicking the complex spike (S) protein folding with proper posttranslational modification to mount a robust immune response against the highly virulent PEDV, two baculoviruses displaying the full-length S protein (S-Bac) and the S1 protein (S1-Bac) of the virulent Taiwan genotype 2b (G2b) PEDV Pintung 52 (PEDV-PT) strain were constructed. Intramuscular immunizations of mice and piglets with the S-Bac and S1-Bac demonstrated significantly higher levels of systemic anti-PEDV S-specific IgG, as compared with control group. Our results also showed that piglets in the S-Bac group elicited superior PEDV-specific neutralizing antibodies than those of the S1-Bac and control groups. The highly virulent PEDV-PT strain challenge experiment showed that piglets immunized with S-Bac and S1-Bac showed milder clinical symptoms with significantly less fecal viral shedding as compared with non-immunized control piglets. More importantly, piglets immunized with the S-Bac exhibited no to mild clinical signs, with a delayed, minimal viral shedding. Our results demonstrated that the S-Bac could serve as a safe, easy to manipulate, and effective vaccine candidate against the PEDV infection. MDPI 2018-06-27 /pmc/articles/PMC6071207/ /pubmed/29954081 http://dx.doi.org/10.3390/v10070346 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chang, Chia-Yu
Hsu, Wei-Ting
Chao, Yu-Chan
Chang, Hui-Wen
Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy
title Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy
title_full Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy
title_fullStr Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy
title_full_unstemmed Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy
title_short Display of Porcine Epidemic Diarrhea Virus Spike Protein on Baculovirus to Improve Immunogenicity and Protective Efficacy
title_sort display of porcine epidemic diarrhea virus spike protein on baculovirus to improve immunogenicity and protective efficacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071207/
https://www.ncbi.nlm.nih.gov/pubmed/29954081
http://dx.doi.org/10.3390/v10070346
work_keys_str_mv AT changchiayu displayofporcineepidemicdiarrheavirusspikeproteinonbaculovirustoimproveimmunogenicityandprotectiveefficacy
AT hsuweiting displayofporcineepidemicdiarrheavirusspikeproteinonbaculovirustoimproveimmunogenicityandprotectiveefficacy
AT chaoyuchan displayofporcineepidemicdiarrheavirusspikeproteinonbaculovirustoimproveimmunogenicityandprotectiveefficacy
AT changhuiwen displayofporcineepidemicdiarrheavirusspikeproteinonbaculovirustoimproveimmunogenicityandprotectiveefficacy